Update on vaccine production at biontech's manufacturing site in marburg

Mainz, germany, february 10, 2021 (globe newswire) - we started the manufacturing process at the marburg facility with the execution of the first step: the production of mrna, which is the active pharmaceutical ingredient of the pfizer-biontech covid-19 vaccine. a single mrna batch of the current scale is sufficient to produce around eight million vaccine doses. biontech plans to start the manufacturing of the drug substance based on the new manufacturing license granted from darmstadt regional administrative council for the amended facility in marburg.
BNTX Ratings Summary
BNTX Quant Ranking